RETRACTION: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression (Retraction of Vol 13, art no 24, 2020)

被引：0
|
作者：
Song, Huajie [1 ]
Li, Dan [1 ]
Wang, Xiaojing [2 ]
Fang, Erhu [1 ]
Yang, Feng [1 ]
Hu, Anpei [1 ]
Wang, Jianqun [1 ]
Guo, Yanhua [1 ]
Liu, Yang [1 ]
Li, Hongjun [3 ]
Chen, Yajun [3 ]
Huang, Kai [2 ]
Zheng, Liduan [2 ,3 ]
Tong, Qiangsong [1 ,2 ]
机构：
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Ctr Human Genom Res, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pathol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
来源：
JOURNAL OF HEMATOLOGY & ONCOLOGY | 2023年 / 16卷 / 01期
关键词：
D O I：
10.1186/s13045-023-01493-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 19 条
  • [1] Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
    Huajie Song
    Dan Li
    Xiaojing Wang
    Erhu Fang
    Feng Yang
    Anpei Hu
    Jianqun Wang
    Yanhua Guo
    Yang Liu
    Hongjun Li
    Yajun Chen
    Kai Huang
    Liduan Zheng
    Qiangsong Tong
    Journal of Hematology & Oncology, 16
  • [2] RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
    Huajie Song
    Dan Li
    Xiaojing Wang
    Erhu Fang
    Feng Yang
    Anpei Hu
    Jianqun Wang
    Yanhua Guo
    Yang Liu
    Hongjun Li
    Yajun Chen
    Kai Huang
    Liduan Zheng
    Qiangsong Tong
    Journal of Hematology & Oncology, 13
  • [3] RETRACTED: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression (Retracted Article)
    Song, Huajie
    Li, Dan
    Wang, Xiaojing
    Fang, Erhu
    Yang, Feng
    Hu, Anpei
    Wang, Jianqun
    Guo, Yanhua
    Liu, Yang
    Li, Hongjun
    Chen, Yajun
    Huang, Kai
    Zheng, Liduan
    Tong, Qiangsong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [4] RETRACTION: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target (Retraction of Vol 1, art no 486407, 2014)
    Hung, C. -H.
    Chiu, Y. -C.
    Chen, C. -H.
    Hu, T. -H.
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [5] RETRACTION: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis (Retraction of Vol 19, art no 85, 2020)
    Liang, Yiran
    Song, Xiaojin
    Li, Yaming
    Chen, Bing
    Zhao, Wenjing
    Wang, Lijuan
    Zhang, Hanwen
    Liu, Ying
    Han, Dianwen
    Zhang, Ning
    Ma, Tingting
    Wang, Yajie
    Ye, Fangzhou
    Luo, Dan
    Li, Xiaoyan
    Yang, Qifeng
    MOLECULAR CANCER, 2022, 21 (01)
  • [6] RETRACTION: Lidocaine Suppresses Cell Proliferation and Aerobic Glycolysis by Regulating circHOMER1/miR-138-5p/HEY1 Axis in Colorectal Cancer (Retraction of Vol 12, Pg 5009, 2020)
    Du, J.
    Zhang, L.
    Ma, H.
    Wang, Y.
    Wang, P.
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7341 - 7341
  • [7] RETRACTION: LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APE1 Axis (Retraction of Vol 13, Pg 10607, 2020)
    Lu, M.
    Liu, D.
    Li, Y.
    ONCOTARGETS AND THERAPY, 2022, 15 : 701 - 701
  • [8] RETRACTION: Long non-coding RNA DLX6-AS1 regulates neuroblastoma progression by targeting YAP1 via miR-497-5p (Retraction of Vol 252, art no 117657, 2020)
    Li, Changchun
    Wang, Shan
    Yang, Chao
    LIFE SCIENCES, 2022, 294
  • [9] RETRACTION: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis (Retraction of Vol 10, art no 3389, 2020)
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] RETRACTION: lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis (Retraction of Vol 13, Pg 4523, 2020)
    Wei, P.
    Yang, J.
    Zhang, D.
    Cui, M.
    Li, L.
    ONCOTARGETS AND THERAPY, 2022, 15 : 133 - 133
12